A new International Council for Harmonisation (ICH) final guidance released by the FDA Dec. 6 said selective safety data collection mainly should be used in “interventional clinical trials primarily in the post-approval setting.” However, “in some circumstances, it may be considered for use in the pre-approval setting.” Selective safety data collection refers to the reduced c... Read More